Correlation Engine 2.0
Clear Search sequence regions


  • analysis costs (3)
  • costs control (2)
  • georgia (2)
  • humans (1)
  • insulin (1)
  • moldova (2)
  • pharmacy (1)
  • self (1)
  • self control (8)
  • Sizes of these terms reflect their relevance to your search.

    The aim: To pharmacoeconomic analysis of direct medical costs for self-control of diabetes in Ukraine, Moldova and Georgia. Our observational, cross-sectional study aims at finding out the real costs of covering expenses in order to make decisions on the reimbursement of self-control means. Materials and methods: 1) International and national clinical guidelines for diabetes; 2) information about the prices of glucometers, test strips from online pharmacy services. Systematization, generalization and pharmacoeconomic analysis of direct medical costs were used in the study. Results: Based on the generalization of recommendations on the frequency of blood glucose control, 3 scenarios were identified, according to which the costs were calculated: Type 1 diabetes; Type 2 diabetes (insulin therapy); Type 2 diabetes (oral hypoglycemic therapy). The authors conducted pharmacoeconomic analysis of direct medical costs for self-control of DM for PWD in Ukraine, Moldova and Georgia. The study shows that the lowest cost of self-control is provided in Ukraine, in addition, Ukraine has a wider choice of glucometers and test strips. It was revealed that the pharmaceutical markets for glycometers in the three countries depends on the import of equipment. Conclusions: It is advisable to introduce in Ukraine the reimbursement of self-control devices, namely, glucometers and test strips for all categories of PWD, which will contribute to self-control and, as a result, will be able to prevent the development of complications. Certification of continuous glucose monitoring systems will increase access to new technologies that are already widely used in many countries.

    Citation

    Iryna O Vlasenko, Anastasia A Babileva, Ramaz B Kurashvili, Lena L Davtian. COMPARATIVE PHARMACOECONOMIC ANALYSIS OF SELF-CONTROL OF DIABETES MELLITUS USING GLUCOMETERS. Wiadomosci lekarskie (Warsaw, Poland : 1960). 2022;75(5 pt 1):1105-1111

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35758486

    View Full Text